A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study will be conducted to compare Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy.
Epistemonikos ID: cf5bda42e7087a3baf940784f17c6fae1e587272
First added on: Aug 16, 2025